HSCS
HeartSciences Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.58
+6.55%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
401.4x
Market Cap
$16.13M
MomentumView details →
1D Return
+6.55%
YTD Return
+14.40%
RSI (14)
73.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
401.4x
Market Cap
$16.13M
RSI (14)
73.1
MomentumView details →
1D Return
+6.55%
YTD Return
+14.40%
SummaryUpdated Jan 1, 2026
Heart Test Laboratories, Inc. (NASDAQ:HSCS) is a medical technology company founded in 2007 and headquartered in Southlake, Texas. The company went public in June 2022, focusing on developing and commercializing advanced cardiovascular diagnostic devices. Heart Test Laboratories represents an early-stage medical device company attempting to bring innovative electrocardiography technology to market, though it has faced significant challenges in generating meaningful revenue since its public debut.
Similar companies
Latest newsMore news →
HeartSciences Inc. sold and issued 411,522 shares of its common stock to Fortitude Mining Holdings, Inc. at $2.43 per share, raising approximately $1.0 million in a private placement.18d agoHeartSciences Inc. granted a retention bonus of 425,000 restricted shares of common stock to Andrew Simpson under its 2023 Equity Incentive Plan, vesting over one year following the closing of its pending merger with Fortitude Mining HoldCo, subject to continued employment.71d ago